Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Reduction of Hypertrophic Skin Scarring”

7 trials

Showing 7 of 7 results

Not applicableStudy completedNCT04827680
What this trial is testing

Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring

Who this might be right for
Acne Scars - Mixed Atrophic and Hypertrophic
Venus Concept 20
Testing effectiveness (Phase 2)Study completedNCT01346969
What this trial is testing

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

Who this might be right for
Reduction in Hypertrophic Skin Scarring
Pfizer 68
Testing effectiveness (Phase 2)Study completedNCT01494922
What this trial is testing

Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001

Who this might be right for
Reduction in Severity of Skin Scarring
Pfizer 14
Large-scale testing (Phase 3)Study completedNCT03887377
What this trial is testing

The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation

Who this might be right for
ScarHypertrophic ScarMammary Disorder
Henry Ford Health System 22
Not applicableWithdrawnNCT04364217
What this trial is testing

Pain and Itch Reduction in Burn Scars Treated With Fractional CO2 Laser

Who this might be right for
Hypertrophic ScarBurn Scar
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT01730339
What this trial is testing

Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery

Who this might be right for
Reduction of Hypertrophic Skin Scarring
Pfizer 103
Testing effectiveness (Phase 2)Study completedNCT04877756
What this trial is testing

Study to Evaluate Efficacy of OLX10010 in Reducing Recurrence of Hypertrophic Scarring After Scar Revision Surgery

Who this might be right for
Hypertrophic Scar
Olix Pharmaceuticals, Inc. 22

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation